Ameriprise
SCPH

Ameriprise’s scPharmaceuticals SCPH Stock Holding History

Ameriprise’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85,863
Closed -$431K – 3929
2024
Q1 		$431K Sell
85,863
-2,009
-2% -$11.3K ﹤0.01% 3464
2023
Q4 		$551K Sell
87,872
-12,727
-13% -$72.9K ﹤0.01% 3423
2023
Q3 		$716K Sell
100,599
-894
-0.9% -$7.04K ﹤0.01% 3280
2023
Q2 		$1.03M Buy
101,493
+4,896
+5% +$51.1K ﹤0.01% 3158
2023
Q1 		$876K Buy
+96,597
New +$708K ﹤0.01% 3217

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return